Palo Alto, United States
NanoSpun Technologies is an innovative biotech company focused on harnessing the power of biology to create revolutionary live-active cell-based products and solutions. As a global pioneer in the biotech, advanced materials, and bioprinting spaces, the company is leading the way to a whole new generation of cell-based products and solutions through the intelligent application of NanoSpun biological fabrics.
No other company can do what NanoSpun does. They encapsulate live and active biological cells and organisms, including bacteria, yeast, algae, plant cells, and mammalian to produce living tissues and fabrics with a wide application across many industries. The company's current market focus is to revolutionize Skincare and Bioprocessing.
NanoSpun Skincare aims to protect and enhance the skin’s microbiome with two lines of sheet face masks and tissues designed specifically to address a broad spectrum of skin types, conditions, climates, seasonalities, and age groups. NanoSpun UltraBio, the company's flagship product, is industry-disrupting probiotic face masks and tissues made from live-active probiotics and enhanced with plant-based nutrients and superfoods. On the other hand, NanoSpun Ultra offers an entry-level option with thin and silky tissues infused with plant-based nutrients and superfoods, providing similar advantages to UltraBio products without live-active probiotics.
NanoSpun Bioprocessing is revolutionizing bioprocessing by delivering groundbreaking solutions to the rapidly growing bioproduction, fermentation, and perfusion markets. The company offers a novel, highly effective, efficient, and easy to use solution across any industry utilizing organisms and cells within their production processes. Their next-generation "biology as a cassette" solution represents a complete transformation in cell-based processes and dramatically improves bioproduction practices. Founded in 2011 and headquartered in the United States, NanoSpun Technologies is positioned at the forefront of innovation in the Biotechnology industry.